Literature DB >> 33219490

A case of autoimmune gastritis with fundic gland polyp-like pseudopolyps presenting with nodular enterochromaffin-like cell hyperplasia.

Tohru Kotera1, Takahiro Takemoto2, Ryoji Kushima3, Ken Haruma4.   

Abstract

Pseudopolyps, a type of remnant oxyntic mucosa on a background of corpus-restricted mucosal atrophy, are a characteristic endoscopic finding in autoimmune gastritis (AIG). Linear or nodular enterochromaffin-like (ECL) cell hyperplasia, a characteristic histopathological finding of AIG, is not generally found in pseudopolyps. We report a case of AIG with fundic gland polyp (FGP)-like pseudopolyps containing nodular ECL cell hyperplasia. A 64-year-old man underwent esophagogastroduodenoscopy, which revealed atrophic changes limited to the corpus, with a normal antrum. The greater curvature was less atrophic than the lesser curvature. Sessile or semipedunculated polypoid lesions were observed on the greater curvature and on the anterior and posterior walls of the corpus. The polypoid lesions resembled FGPs, although some were larger than FGPs generally are. Histologically, non-atrophic fundic glands with parietal cell pseudohypertrophy were observed in the upper regions of the polypoid lesions. By contrast, at the base of the lesions, where linear and nodular ECL cell hyperplasia was identified by immunohistochemical staining, destruction of fundic glands with lymphocytic infiltration, loss of parietal cells, and pseudopyloric metaplasia was observed. Anti-parietal cell antibody positivity and hypergastrinemia confirmed the diagnosis of AIG with pseudopolyps. FGP-like pseudopolyps can, therefore, be present with nodular ECL cell hyperplasia in AIG.

Entities:  

Keywords:  Autoimmune gastritis; Enterochromaffin-like cell hyperplasia; Fundic gland polyp; Pseudopolyp

Mesh:

Year:  2020        PMID: 33219490     DOI: 10.1007/s12328-020-01294-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  8 in total

1.  Omeprazole-induced pseudohypertrophy of gastric parietal cells.

Authors:  M Stolte; B Bethke; G Rühl; M Ritter
Journal:  Z Gastroenterol       Date:  1992-02       Impact factor: 2.000

2.  Fundic gland polyps developing during omeprazole therapy.

Authors:  H M el-Zimaity; F W Jackson; D Y Graham
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

3.  Gastric pseudopolyposis: a new clinical manifestation of type A gastritis.

Authors:  T Ikeda; I Senoue; M Hara; Y Tsutsumi; S Harasawa; T Miwa
Journal:  Am J Gastroenterol       Date:  1985-02       Impact factor: 10.864

Review 4.  Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.

Authors:  E Solcia; R Fiocca; L Villani; O Luinetti; C Capella
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

5.  Active autoimmune gastritis without total atrophy of the glands.

Authors:  M Stolte; K Baumann; B Bethke; M Ritter; E Lauer; H Eidt
Journal:  Z Gastroenterol       Date:  1992-10       Impact factor: 2.000

6.  Features of the atrophic corpus mucosa in three cases of autoimmune gastritis revealed by magnifying endoscopy.

Authors:  Kazuyoshi Yagi; Atsuo Nakamura; Atsuo Sekine; David Graham
Journal:  Case Rep Med       Date:  2012-07-03

7.  Fundic Gland Polyposis Associated with Proton-Pump Inhibitor Use.

Authors:  Kenta Hamada; Yoji Takeuchi; Tomofumi Akasaka; Hiroyasu Iishi
Journal:  Eur J Case Rep Intern Med       Date:  2017-03-13

8.  Multiple Pseudopolyps Presenting as Reddish Nodules Are a Characteristic Endoscopic Finding in Patients with Early-stage Autoimmune Gastritis.

Authors:  Tohru Kotera; Keishi Oe; Ryoji Kushima; Ken Haruma
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.